| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | AMGEN INC | 35,773 | 5,807,000 | 3.84% | ||
| 52 | REGENERON PHARMACEUTICALS | 10,714 | 5,816,000 | 3.84% | ||
| 53 | NEKTAR THERAPEUTICS COM | 348,583 | 5,874,000 | 3.88% | ||
| 54 | ALEXION PHARMACEUTIC | 32,969 | 6,289,000 | 4.15% | ||
| 55 | IONIS PHARMACEUTICALS INC COM | 102,459 | 6,345,000 | 4.19% | ||
| 56 | ALKERMES PLC | 87,415 | 6,939,000 | 4.58% | ||
| 57 | ISHARES TR | 31,600 | 10,691,000 | 7.06% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-16-004260, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
